Not Medicare Enrolled

Dr. Stefan Gluck, MD

Q: Does Dr. Gluck receive payments from pharmaceutical companies?

Yes. Dr. Gluck received a total of $49,207 from 9 companies across 38 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Gluck) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Hematology & Oncology · Miami, FL

1611 NW 12TH AVE, Miami, FL 33136

3055851111

Registered in NPPES since 2006

NPI: 1417913781 verify on NPPES ↗

Moderate

DATA COVERAGE

Data in 2 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Gluck from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Gluck? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gluck

Dr. Stefan Gluck is a hematology & oncology specialist in Miami, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Gluck received a total of $49,207 from 9 pharmaceutical and/or device companies across 38 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gluck is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $49,207 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$49,207

Total received (2018-2024)

Avg $8,201/year across 6 years

Top 14% in FL for hematology & oncology

A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.

Companies

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$2,142

2023

$1,650

2021

$132

2020

$44,898

2019

$303

2018

$81

Payments by company (2024)

Novartis Pharmaceuticals Corporation

$2,000

Coherus Biosciences Inc.

$142

Top 3 companies account for 100.0% of 2024 payments

All-time payments by company (2018-2024) ›

Puma Biotechnology, Inc.

$45,015

Novartis Pharmaceuticals Corporation

$2,000

Secura Bio, Inc.

$1,650

Coherus Biosciences Inc.

$142

AstraZeneca Pharmaceuticals LP

$132

NanoString Technologies, Inc.

$117

Celgene Corporation

$81

Veracyte, Inc.

$43

QT Ultrasound LLC

$26

Top 3 companies account for 98.9% of all-time payments

Associated products mentioned in payments ›

Abraxane · COPIKTRA · KISQALI · NERLYNX · Nerlynx · PROSIGNA ASSAY · QTScanner · Udenyca

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for a hematology & oncology specialist in Miami?
Compare hematology & oncology specialists in the Miami area by procedure volume, costs, and industry payment transparency.

Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas

179

County median income

$68,694

Nearest hospital to ZIP centroid (approximate)

JACKSON HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	— Not enrolled	N/A
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not included	N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gluck is a hematology & oncology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Gluck receive payments from pharmaceutical companies?

Yes. Dr. Gluck received a total of $49,207 from 9 companies across 38 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Gluck) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city

Hematology & Oncology Specialists in Miami

Browse hematology & oncology specialists in Miami ranked by procedure volume and transparency data.

Highest volume

Top Hematology & Oncology Specialists in FL

Hematology & oncology specialists ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Hematology & Oncology Specialists in FL

Which FL hematology & oncology specialists receive the most from drug and device companies.

By company

Puma Biotechnology, Inc. Payments to Doctors

See all physicians who received payments from Puma Biotechnology, Inc.

By company

Novartis Pharmaceuticals Corporation Payments to Doctors

See all physicians who received payments from Novartis Pharmaceuticals Corporation.

By company

Secura Bio, Inc. Payments to Doctors

See all physicians who received payments from Secura Bio, Inc.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology